0001716747-23-000001.txt : 20230811 0001716747-23-000001.hdr.sgml : 20230811 20230811140044 ACCESSION NUMBER: 0001716747-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 EFFECTIVENESS DATE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nivagen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001716747 IRS NUMBER: 271447740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489503 FILM NUMBER: 231163052 BUSINESS ADDRESS: STREET 1: 3100 FITE CIRCLE STREET 2: SUITE 208 CITY: SACRAMENTO STATE: CA ZIP: 95827 BUSINESS PHONE: 916-364-1662 MAIL ADDRESS: STREET 1: 3100 FITE CIRCLE STREET 2: SUITE 208 CITY: SACRAMENTO STATE: CA ZIP: 95827 D 1 primary_doc.xml X0708 D LIVE 0001716747 Nivagen Pharmaceuticals, Inc. 3100 FITE CIRCLE SUITE 100 SACRAMENTO CA CALIFORNIA 95827 916-364-1662 DELAWARE None None Corporation true Jwalant Shukla 3100 Fite Circle Suite 208 Saramento CA CALIFORNIA 95827 Executive Officer Director Jaswinder Matharu 7 Hill Street Douglas, Isle of Man X0 UNITED KINGDOM IM1 IEF Director Rob C. Hart 360 Post Street Suite 601 San Francisco CA CALIFORNIA 94108 Director Michael Kulper 3050 Fite Circle Suite 100 Sacramento CA CALIFORNIA 95827 Director Praneel Deo 3050 Fite Circle Suite 100 Sacramento CA CALIFORNIA 95827 Executive Officer Gopal Patel 3050 Fite Cirle Suite 100 Sacramento CA CALIFORNIA 95827 Executive Officer Dasaradhi Lakkaraju 3050 Fite Circle Suite 100 Sacramento CA CALIFORNIA 95827 Executive Officer Ashish Sevak 152 Stuart Street Paramus NJ NEW JERSEY 07652 Director Pharmaceuticals Decline to Disclose 06b false 2023-06-16 false true false 0 5000005 5000005 0 false 1 0 0 0 false Nivagen Pharmaceuticals, Inc. /S/ Jawlant Shukla Jwalant Shukla CEO 2023-08-09